J P Heaton

Summary

Affiliation: Queen's University
Country: Canada

Publications

  1. ncbi Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine
    J P Heaton
    Departments of Urology and Pharmacology and Toxicology, Queen s University, Kingston, Ontario, Canada K7L 2V7
    Neurosci Biobehav Rev 24:561-9. 2000
  2. ncbi Characterising the benefit of apomorphine SL (Uprima) as an optimised treatment for representative populations with erectile dysfunction
    J P Heaton
    Queen s University, Kingston, Ontario, Canada
    Int J Impot Res 13:S35-9. 2001
  3. ncbi Endocrine causes of impotence (nondiabetes)
    Jeremy P W Heaton
    Queen s University and Kingston General Hospital, 76 Stuart Street, Kingston, Ontario K7L 2V7, Canada
    Urol Clin North Am 30:73-81. 2003
  4. ncbi Andropause--a multisystem disease
    J P Heaton
    Queen's University, Kingston General Hospital, Kingston, Ontario, Canada
    Can J Urol 8:1213-22. 2001
  5. ncbi Key issues from the clinical trials of apomorphine SL
    J P Heaton
    Queen's University, Kingston General Hospital, Ontario, Canada
    World J Urol 19:25-31. 2001
  6. ncbi Hormonal erectile dysfunction. Evaluation and management
    A Morales
    Department of Urology, Queen's University, Kingston, Ontario, Canada
    Urol Clin North Am 28:279-88. 2001
  7. ncbi Causes of erectile dysfunction
    Jeremy P W Heaton
    Departments of Urology and Pharmacology and Toxicology, Queen s University, 76 Stuart Street, Kingston, Ontario, Canada
    Endocrine 23:119-23. 2004
  8. ncbi Lower urinary tract disease: what are we trying to treat and in whom?
    Jeremy P W Heaton
    Queen s University, 76 Stuart Street, Kingston, Ontario, Canada K7L 2V7
    Br J Pharmacol 147:S2-13. 2006
  9. ncbi Smoking and other lifestyle factors in relation to erectile dysfunction
    Jane Y Polsky
    Department of Community Health and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada
    BJU Int 96:1355-9. 2005
  10. ncbi Point: urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male
    Jeremy P W Heaton
    Department of Urology, Queen's University, Kingston, Ontario, Canada
    Can J Urol 9:1677-80. 2002

Collaborators

Detail Information

Publications11

  1. ncbi Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine
    J P Heaton
    Departments of Urology and Pharmacology and Toxicology, Queen s University, Kingston, Ontario, Canada K7L 2V7
    Neurosci Biobehav Rev 24:561-9. 2000
    ..Implications for the further development of neuropharmacological agents in this area are discussed...
  2. ncbi Characterising the benefit of apomorphine SL (Uprima) as an optimised treatment for representative populations with erectile dysfunction
    J P Heaton
    Queen s University, Kingston, Ontario, Canada
    Int J Impot Res 13:S35-9. 2001
    ..Given the need for customisation of therapy to individual patient needs, the clinical profile of apomorphine SL would indicate that it will make a most welcome addition to the physician's armamentarium against ED...
  3. ncbi Endocrine causes of impotence (nondiabetes)
    Jeremy P W Heaton
    Queen s University and Kingston General Hospital, 76 Stuart Street, Kingston, Ontario K7L 2V7, Canada
    Urol Clin North Am 30:73-81. 2003
    ..Other, nondiabetic, endocrine abnormalities may need to be considered in the management or the patient with ED...
  4. ncbi Andropause--a multisystem disease
    J P Heaton
    Queen's University, Kingston General Hospital, Kingston, Ontario, Canada
    Can J Urol 8:1213-22. 2001
    ..The object of treatment is improvement in the index clinical domains and biochemical normalization. Contraindications include known or suspected prostate or breast cancer...
  5. ncbi Key issues from the clinical trials of apomorphine SL
    J P Heaton
    Queen's University, Kingston General Hospital, Ontario, Canada
    World J Urol 19:25-31. 2001
    ..Efficacy has been shown in men with cardiovascular disease and severe grades of ED...
  6. ncbi Hormonal erectile dysfunction. Evaluation and management
    A Morales
    Department of Urology, Queen's University, Kingston, Ontario, Canada
    Urol Clin North Am 28:279-88. 2001
    ....
  7. ncbi Causes of erectile dysfunction
    Jeremy P W Heaton
    Departments of Urology and Pharmacology and Toxicology, Queen s University, 76 Stuart Street, Kingston, Ontario, Canada
    Endocrine 23:119-23. 2004
    ....
  8. ncbi Lower urinary tract disease: what are we trying to treat and in whom?
    Jeremy P W Heaton
    Queen s University, 76 Stuart Street, Kingston, Ontario, Canada K7L 2V7
    Br J Pharmacol 147:S2-13. 2006
    ..Using an approach based on patient reported outcomes to therapeutic targets not only widens the range of conditions, but also the patient types who can be considered as having LUTD...
  9. ncbi Smoking and other lifestyle factors in relation to erectile dysfunction
    Jane Y Polsky
    Department of Community Health and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada
    BJU Int 96:1355-9. 2005
    ..CONCLUSION: There was a greater risk of ED among former smokers, and the suggestion of a dose-response relationship with cumulative smoking...
  10. ncbi Point: urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male
    Jeremy P W Heaton
    Department of Urology, Queen's University, Kingston, Ontario, Canada
    Can J Urol 9:1677-80. 2002
    ..The good practice of urology includes the use of androgen replacement therapy in men who need it and have been assessed for the presence of cancer of the prostate...
  11. ncbi Pesticides and polychlorinated biphenyls as potential risk factors for erectile dysfunction
    Jane Y Polsky
    Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen s University, Kingston, Ontario, Canada
    J Androl 28:28-37. 2007
    ..To our knowledge, this study is the first to investigate the possible relationship between plasma levels of organochlorines and ED risk, and results do not provide evidence of an association...